Cefmenoxime

Cefmenoxime

Systematic (IUPAC) name
(6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)- 2-methoxyimino-acetyl]amino}-3-[(1-methyltetrazol- 5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylic acid
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Intramuscular, intravenous
Pharmacokinetic data
Bioavailability	100% (given IM)
Protein binding	50% to 70%
Metabolism	Negligible
Biological half-life	1 hour
Excretion	Renal, unchanged
Identifiers
CAS Number	65085-01-0
ATC code	J01DD05 (WHO)
PubChem	CID 9570757
DrugBank	DB00267
ChemSpider	7845223
UNII	KBZ4844CXN
KEGG	D07641
ChEBI	CHEBI:55490
ChEMBL	CHEMBL1201224
Chemical data
Formula	C16H17N9O5S3
Molar mass	511.562 g/mol
SMILES O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=N\OC)/c3nc(sc3)N)CSc4nnnn4C)C(=O)O
InChI InChI=1S/C16H17N9O5S3/c1-24-16(20-22-23-24)33-4-6-3-31-13-9(12(27)25(13)10(6)14(28)29)19-11(26)8(21-30-2)7-5-32-15(17)18-7/h5,9,13H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29)/b21-8-/t9-,13-/m1/s1 Key:HJJDBAOLQAWBMH-YCRCPZNHSA-N
(what is this?)  (verify)

Cefmenoxime is a third-generation cephalosporin antibiotic.

External links

• DDB 30892

• Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Deguchi K, Oda S, Tanaka S, Nakane Y, Fukumoto T (1995). "Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis". Jpn J Antibiot 48 (5): 602–9. PMID 7637194.
• Paladino J, Fell R (1994). "Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia.". Ann Pharmacother 28 (3): 384–9. doi:10.1177/106002809402800316. PMID 8193431.
• Duncker G, Reich U, Krausse R (1994). "Cefmenoxime in corneal organ culture.". Ophthalmologica 208 (5): 262–6. doi:10.1159/000310505. PMID 7816419.